Advertisement
Home 2025

Archives

RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization

0

Reduction in 2024-2025 RSV-associated hospitalization rates seen among infants aged 0 to 7 months with maternal vaccination or nirsevimab

Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis

0

Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality

Since 2010, Fewer Prostatectomies Being Performed for Lowest-Risk Prostate Cancer

0

A more recent prostatectomy was associated with lower likelihood of pGG1 prostatectomy in two cohorts

USPSTF Continues to Recommend Syphilis Screening Early in Pregnancy

0

Early, universal screening recommended; those not screened early should be screened at first opportunity

Survivorship Interest, Knowledge Limited in Head and Neck Cancer Survivors

0

Most patients want to address survivorship topics in one long visit and prefer in-person visits

Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD

0

Time to first moderate or severe exacerbation longer with mepolizumab in patients with COPD, history of exacerbations, eosinophil count ≥300 cells/µL

Diet Quality Plays Role in Age at Menarche

0

Findings independent of body mass index-for-age or height

Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer

0

Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors

BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection

0

Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions

No Causal Link Seen Between Stimulant Prescription, Psychotic Experience

0

No evidence observed for causal effect of stimulant prescription on subsequent psychotic experiences when applying doubly robust estimation